Wyeth chairman Robert Essner to retire

Share this article:
Robert Essner to retire
Robert Essner to retire

Wyeth has announced that Robert Essner will retire as chairman, effective June 27th, 2008.  Bernard Poussot, Wyeth's president and CEO will take over as chairman upon Essner's departure.

“Bob successfully led Wyeth's transformation from a holding company to what is now a world leader in pharmaceuticals that has grown in annual revenue from $14 billion in 2001 to more than $22 billion in 2007,” said Poussot in a statement.

Essner's exit from the chairman position, held since January 2003, completes the succession process which began in April 2006, when Poussot was promoted to president and vice chairman.  Poussot replaced Essner as Wyeth's CEO in January 2007.

Essner has worked at Wyeth since 1989, and was promoted to CEO in May 2001.

Share this article:

Email Newsletters

More in News

In sunny world of LASIK marketers, a dark underbelly

In sunny world of LASIK marketers, a dark ...

Last week, the former FDA branch chief who originally approved LASIK machines asked FDA to reconsider its denial last month of his petition to ban these devices.

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.